Trial
NCT05496569
TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Dedifferentiated Liposarcoma
Intervention
TQB3616 capsule
Why stopped
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-21